Labour and non-labour market productivity in chinese patients with systemic lupus erythematosus

Rheumatology

Volumn 51, Issue 2, 2012, Pages 284-292

  Zhu, Tracy Y ^a   Tam, Lai Shan ^a   Li, Edmund K ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Non labour market activities; Productivity; Systemic lupus erythematosus; Work disability

Indexed keywords

ACADEMIC ACHIEVEMENT; ADULT; ARTICLE; CHINESE; DISEASE DURATION; FEMALE; FUNCTIONAL ASSESSMENT; HEALTH STATUS; HUMAN; LEISURE; MAJOR CLINICAL STUDY; MALE; MARKET; MEDICAL HISTORY; PLEURISY; PRIORITY JOURNAL; PRODUCTIVITY; QUESTIONNAIRE; SELF REPORT; SYSTEMIC LUPUS ERYTHEMATOSUS; WELLBEING; WORK DISABILITY;

ACTIVITIES OF DAILY LIVING; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DISABILITY EVALUATION; DISABLED PERSONS; EFFICIENCY; FEMALE; HEALTH STATUS; HONG KONG; HUMANS; LOGISTIC MODELS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; OCCUPATIONS; OUTPATIENTS; PAIN MEASUREMENT; QUALITY OF LIFE; QUESTIONNAIRES; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84856091580     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ker247     Document Type: Article

References (43)

1. D'Cruz DP, Khamashta MA, Hughes GR. Systemic lupus erythematosus. Lancet 2007;369:587-96.
2. Clarke A. Economic impact of lupus. Am J Manag Care 2001;7:S496-501.
3. Bertoli AM, Fernandez M, Alarcon GS, Vila LM, Reveille JD. Systemic lupus erythematosus in a multiethnic US cohort LUMINA (XLI): factors predictive of self-reported work disability. Ann Rheum Dis 2007;66: 12-17.
4. Stein H, Walters K, Dillon A, Schulzer M. Systemic lupus erythematosus-a medical and social profile. J Rheumatol 1986;13:570-6.
5. Yelin E, Tonner C, Trupin L et al. Work loss and work entry among persons with systemic lupus erythematosus: comparisons with a national matched sample. Arthritis Rheum 2009;61:247-58.
6. Yelin ETL, Katz P, Criswell L, Yazdany J, Gillis J, Panopalis P. Work dynamics among persons with systemic lupus erythematosus. Arthritis Rheum 2007;57: 56-63.
7. Campbell R Jr, Cooper GS, Gilkeson GS. The impact of systemic lupus erythematosus on employment. J Rheumatol 2009;36:2470-5.
8. Partridge AJ, Karlson EW, Daltroy LH et al. Risk factors for early work disability in systemic lupus erythematosus: results from a multicenter study. Arthritis Rheum 1997;40: 2199-206.
9. Al Dhanhani AM, Gignac MA, Su J, Fortin PR. Work disability in systemic lupus erythematosus. Arthritis Rheum 2009;61:378-85.
10. Baker K, Pope J, Fortin P, Silverman E, Peschken C. Work disability in systemic lupus erythematosus is prevalent and associated with socio-demographic and disease related factors. Lupus 2009;18:1281-8.
11. Yelin E, Trupin L, Katz P et al. Work dynamics among persons with systemic lupus erythematosus. Arthritis Rheum 2007;57:56-63.
12. Baker K, Pope J. Employment and work disability in systemic lupus erythematosus: a systematic review. Rheumatology 2009;48:281-4.
13. Clarke AE, Penrod J, St Pierre Y et al. Underestimating the value of women: assessing the indirect costs of women with systemic lupus erythematosus. Tri-Nation Study Group. J Rheumatol 2000;27:2597-604.
14. Zhu TY, Tam LS, Lee VW, Lee KK, Li EK. Systemic lupus erythematosus with neuropsychiatric manifestation incurs high disease costs: a cost-of-illness study in Hong Kong. Rheumatology 2009;48:564-8.
15. Zhu TY, Tam LS, Li EK. Cost of illness studies in systemic lupus erythematosus: A systematic review. Arthritis Care Res 2011;63:751-60.
16. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40: 1725.
17. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992;35:630-40.
18. Gladman D, Ginzler E, Goldsmith C et al. The development and initial validation of the Systemic Lupus International Collabourating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996;39:363-9.
19. ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999;42:599-608.
20. Hochberg MC, Chang RW, Dwosh I, Lindsey S, Pincus T, Wolfe F. The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis. Arthritis Rheum 1992;35: 498-502.
21. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-83.
22. Lam CLK, Lauder IJ, Lam TP, Gandek B. Validation and norming of the MOS 36-item short form health survey (SF-36) on the Chinese adult population in Hong Kong. Final Report, Health Services Research Committee Grant (#711026). Hong Kong: Health Services Research Committee 2000. http://fhbgrants.netsoft.net/english/funded-search/funded-search-detail.php?id=145&no=3 (10 May 2011, date last accessed).
23. EuroQol Group. EuroQol-a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy 1990;16:199-208.
24. Khanna S, Pal H, Pandey RM, Handa R. The relationship between disease activity and quality of life in systemic lupus erythematosus. Rheumatology 2004;43:1536-40.
25. Tsuchiya A, Ikeda S, Ikegami N et al. Estimating an EQ-5D population value set: the case of Japan. Health Econ 2002;11:341-53.
26. Rice DP. Cost of illness studies: what is good about them? Inj Prev 2000;6:177-9.
27. Stamm TA, Bauernfeind B, Coenen M et al. Concepts important to persons with systemic lupus erythematosus and their coverage by standard measures of disease activity and health status. Arthritis Rheum 2007;57: 1287-95.
28. Murphy NG, Koolvisoot A, Schumacher R Jr, Von Feldt JM, Callegari PE. Musculoskeletal features in systemic lupus erythematosus and their relationship with disability. J Clin Rheumatol 1998;4:238-45.
29. Utset TO, Fink J, Doninger NA. Prevalence of neurocognitive dysfunction and other clinical manifestations in disabled patients with systemic lupus erythematosus. J Rheumatol 2006;33:531-8.
30. Yazdany J, Yelin EH, Panopalis P, Trupin L, Julian L, Katz PP. Validation of the systemic lupus erythematosus activity questionnaire in a large observational cohort. Arthritis Rheum 2008;59:136-43.
31. Sutcliffe N, Clarke AE, Gordon C, Farewell V, Isenberg DA. The association of socio-economic status, race, psychosocial factors and outcome in patients with systemic lupus erythematosus. Rheumatology 1999;38: 1130-7.
32. Mok CC, Cheung MY, Ho LY, Yu KL, To CH. Risk and predictors of work disability in Chinese patients with systemic lupus erythematosus. Lupus 2008;17:1103-7.
33. Allaire S. Is work disability associated with systemic lupus erythematosus modifiable? J Rheumatol 2008;35: 953-5.
34. Scofield L, Reinlib L, Alarcon GS, Cooper GS. Employment and disability issues in systemic lupus erythematosus: a review. Arthritis Rheum 2008;59: 1475-9.
35. Clarke AE, Esdaile JM, Bloch DA, Lacaille D, Danoff DS, Fries JF. A Canadian study of the total medical costs for patients with systemic lupus erythematosus and the predictors of costs. Arthritis Rheum 1993;36: 1548-59.
36. Panopalis P, Petri M, Manzi S et al. The systemic lupus erythematosus Tri-Nation study: cumulative indirect costs. Arthritis Rheum 2007;57:64-70.
37. Sutcliffe N, Clarke AE, Taylor R, Frost C, Isenberg DA. Total costs and predictors of costs in patients with systemic lupus erythematosus. Rheumatology 2001;40: 37-47.
38. Zhu TY, Tam LS, Lee VW, Lee KK, Li EK. The impact of flare on disease costs of patients with systemic lupus erythematosus. Arthritis Rheum 2009;61:1159-67.
39. Jonsen A, Bengtsson AA, Nived O, Ryberg B, Sturfelt G. Outcome of neuropsychiatric systemic lupus erythematosus within a defined Swedish population: increased morbidity but low mortality. Rheumatology 2002;41:1308-12.
40. Zhu TY, Tam LS, Li EK. Societal costs of rheumatoid arthritis in Hong Kong: a prevalence-based cost-of-illness study. Rheumatology. Advance Access published February 2011;50:1293-301.
41. Zhu TY, Tam LS, Leung YY et al. Socioeconomic burden of psoriatic arthritis in Hong Kong: direct and indirect costs and the influence of disease pattern. J Rheumatol 2010;37:1214-20.
42. Zhu TY, Tam LS, Lee VW et al. Costs and quality of life of patients with ankylosing spondylitis in Hong Kong. Rheumatology 2008;47:1422-5.
43. Utset TO, Chohan S, Booth SA, Laughlin JC, Kocherginsky M, Schmitz A. Correlates of formal work disability in an urban university systemic lupus erythematosus practice. J Rheumatol 2008;35:1046-52.